Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1988 4
1989 1
1994 1
1996 1
1997 1
1998 1
1999 1
2000 1
2004 2
2005 1
2007 1
2010 2
2011 2
2012 1
2016 1
2017 2
2018 2
2021 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.
Macarulla T, Cervantes A, Elez E, Rodríguez-Braun E, Baselga J, Roselló S, Sala G, Blasco I, Danaee H, Lee Y, Ecsedy J, Shinde V, Chakravarty A, Bowman D, Liu H, Eton O, Fingert H, Tabernero J. Macarulla T, et al. Among authors: blasco i. Mol Cancer Ther. 2010 Oct;9(10):2844-52. doi: 10.1158/1535-7163.MCT-10-0299. Epub 2010 Aug 19. Mol Cancer Ther. 2010. PMID: 20724522 Clinical Trial.
Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors.
Cervantes A, Elez E, Roda D, Ecsedy J, Macarulla T, Venkatakrishnan K, Roselló S, Andreu J, Jung J, Sanchis-Garcia JM, Piera A, Blasco I, Maños L, Pérez-Fidalgo JA, Fingert H, Baselga J, Tabernero J. Cervantes A, et al. Among authors: blasco i. Clin Cancer Res. 2012 Sep 1;18(17):4764-74. doi: 10.1158/1078-0432.CCR-12-0571. Epub 2012 Jul 2. Clin Cancer Res. 2012. PMID: 22753585 Clinical Trial.
Cost effectiveness of hepatitis B immunisation strategies.
Hillman AL, Blasco I, Bloom BS, Schwartz JS. Hillman AL, et al. Among authors: blasco i. Pharmacoeconomics. 1994 Feb;5(2):85-7. doi: 10.2165/00019053-199405020-00001. Pharmacoeconomics. 1994. PMID: 10146900 No abstract available.
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Gambardella V, Lombardi P, Carbonell-Asins JA, Tarazona N, Cejalvo JM, González-Barrallo I, Martín-Arana J, Tébar-Martínez R, Viala A, Bruixola G, Hernando C, Blasco I, Papaccio F, Martínez-Ciarpaglini C, Alfaro-Cervelló C, Seda-García E, Blesa S, Chirivella I, Castillo J, Montón-Bueno JV, Roselló S, Huerta M, Pérez-Fidalgo A, Martín-Martorell P, Insa-Mollá A, Fleitas T, Rentero-Garrido P, Zúñiga-Trejos S, Cervantes A, Roda D. Gambardella V, et al. Among authors: blasco i. Br J Cancer. 2021 Oct;125(9):1261-1269. doi: 10.1038/s41416-021-01502-x. Epub 2021 Sep 7. Br J Cancer. 2021. PMID: 34493820 Free PMC article.
Optimizing donor selection in a cord blood bank.
Solves P, Perales A, Mirabet V, Blasco I, Blanquer A, Planelles D, Larrea L, Monleon J, Carbonell-Uberos F, Angeles Soler M. Solves P, et al. Among authors: blasco i. Eur J Haematol. 2004 Feb;72(2):107-12. doi: 10.1046/j.0902-4441.2003.00187.x. Eur J Haematol. 2004. PMID: 14962247
Validation of the spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire.
Fernández O, Fernández V, Baumstarck-Barrau K, Muñoz L, Gonzalez Alvarez Mdel M, Arrabal JC, León A, Alonso A, López-Madrona JC, Bustamante R, Luque G, Guerrero M, di Cantogno EV, Auquier P; MusiQoL study group of Spain. Fernández O, et al. BMC Neurol. 2011 Oct 18;11:127. doi: 10.1186/1471-2377-11-127. BMC Neurol. 2011. PMID: 22013975 Free PMC article.
27 results